LIPO

Lipella Pharmaceuticals Inc. (NASDAQ:LIPO) is a clinical-stage biotechnology company founded in 2005 and headquartered in Pittsburgh, Pennsylvania. The company went public in December 2022 and focuses on developing innovative drug formulations by reformulating active agents found in existing generic drugs and optimizing these reformulations for new therapeutic applications. Lipella represents a specialized approach within the pharmaceutical industry, seeking to extract additional value from well-established drug compounds through novel delivery methods and formulations.